Featured publications
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects
September 9, 2021
Maas-Bauer K, Lohmeyer JK, Hirai T, Ramos TL, Fazal FM, Litzenburger UM, Yost KE, Ribado JV, Kambham N, Wenokur AS, Lin PY, Alvarez M, Mavers M, Baker J, Bhatt AS, Chang HY, Simonetta F, Negrin RS. Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021 Sep 9;138(10):858-870. doi: 10.1182/blood.2021010887. PMID: 34036317; PMCID: PMC8432044.
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD
June 8, 2021
Hirai T, Lin PY, Simonetta F, Maas-Bauer K, Turkoz M, Mavers M, Baker J, Negrin RS. Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. Blood Adv. 2021 Jun 8;5(11):2528-2538. doi: 10.1182/bloodadvances.2020003272. PMID: 34100904; PMCID: PMC8238485.
Activation of the DR3-TL1A axis in Donor Mice Leads to Regulatory T cell Expansion and Activation with Reduction in Graft-Versus-Host Disease
July 17, 2019
Mavers M, Simonetta F, Nishikii H, Ribado JV, Maas-Bauer K, Alvarez M, Hirai T, Turkoz M, Baker J, Negrin RS. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Front Immunol. 2019 Jul 17;10:1624. doi: 10.3389/fimmu.2019.01624. PMID: 31379829; PMCID: PMC6652149.
Invariant natural killer T cells as suppressors of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
July 31, 2017
Mavers M, Maas-Bauer K, Negrin RS. Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2017 Jul 31;8:900. doi: 10.3389/fimmu.2017.00900. PMID: 28824628; PMCID: PMC5534641.
Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis
January 1, 2012
Mavers M, Cuda CM, Misharin AV, Gierut AK, Agrawal H, Weber E, Novack DV, Haines GK 3rd, Balomenos D, Perlman H. Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis Rheum. 2012 Jan;64(1):141-52. doi: 10.1002/art.33311. PMID: 21898359; PMCID: PMC3253189.
he cyclin dependent kinase domain of p21 is a suppressor of IL-1β mediated inflammation in activated macrophages
March 1, 2009
Scatizzi JC, Mavers M, Hutcheson J, Young B, Shi B, Pope RM, Ruderman EM, Samways DS, Corbett JA, Egan TM, Perlman H. The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur J Immunol. 2009 Mar;39(3):820-5. doi: 10.1002/eji.200838683. PMID: 19189309; PMCID: PMC2734089.